NCT03280394Recruiting
Liquid Biopsy in Mature B-cell Tumors
Prospective, Observational, Multi-centred, Non-interventional Research Project on Plasma Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Tumor Management
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 444 (estimated)
- First submitted
- 6 Sept 2017
- Start date
- 1 Sept 2017
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Oncology Institute of Southern Switzerland
- NCT number
- NCT03280394
What you commit to
- Study type: Observational
- Planned participants: 444
- From 1 Sept 2017 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Male or female adults 18 years or older
- Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- Willing and able to comply with scheduled study procedures
- Evidence of a signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Oncology Research Coordinator of this site? Confirm its status | Bellinzona | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.